Objective:To investigate the effect of Etoposide alone maintenance chemotherapy for small cell lung cancer (SCLC).
2
目的：在进展期非小细胞肺癌(NSCLC)患者一线化疗中，双药联合比但要更有效。
Purpose Doublet chemotherapy is more effective than single-agent as first-line treatment of advanced non-small-cell lung cancer (NSCLC).
3
本文对此药在非小细胞肺癌一线、二线、维持治疗和辅助放化疗方面最新的研究进展进行了回顾和展望。
The latest progresses of pemetrexed in first-line treatment, second-line treatment, maintenance treatment, and adjuvant chemotherapy of non-small cell lung cancer are reviewed in the article.
点击反馈